Chief Financial Officer
Scot has 14 years experience in the London Run-Off Insurance market, and has specialised in APH related liabilities. A former Director of Finance for the worldwide anti-infective and psychiatric drug development division of GlaxoSmithKline plc and Finance Manager of the "APH Division" at Whittington Syndicate Management Limited, Scot qualified as a Chartered Accountant with Coopers & Lybrand in 1994.
Prior to moving into accountancy, Scot graduated with a BSc (Hons) in Molecular Biology and, in addition to his other professional qualifications, Scot has been an Associate Member of the Chartered Institute of Arbitrators since 1997.